Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production
Theranostics · 2023 · 13 (12) · 4182-4196
DOI: 10.7150/thno.83714 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Jun-Ha Hwang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Life Sciences, Korea University, Seoul 02841, Korea. Hauptthemen laut MEDLINE: Nitric Oxide, Liver Diseases. Die Arbeit wurde bisher 44-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Life Sciences, Korea University, Seoul 02841, Korea.
- College of Pharmacy and Graduate School of Pharmaceutical Sciences, Ewha Womans University, Seoul 03760, Korea.
Zitieren
APA
Hwang, J. H., Heo, W., Park, J. I., Kim, K. M., Oh, H. T., Yoo, G. D., Park, J., Shin, S., Do, Y., Jeong, M. G., Hwang, E. S., & Hong, J. H. (2023). Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. Theranostics, 13(12), 4182-4196. https://doi.org/10.7150/thno.83714
Vancouver
Hwang JH, Heo W, Park JI, Kim KM, Oh HT, Yoo GD, et al. Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production. Theranostics. 2023;13(12):4182-4196. doi:10.7150/thno.83714
BibTeX
@article{Hwang2023,
author = {Hwang, Jun-Ha and Heo, Woong and Park, Jung Il and Kim, Kyung Min and Oh, Ho Taek and Yoo, Gi Don and Park, Jeekeon and Shin, Somin and Do, Youjin and Jeong, Mi Gyeong and Hwang, Eun Sook and Hong, Jeong-Ho},
title = {Endothelial TAZ inhibits capillarization of liver sinusoidal endothelium and damage-induced liver fibrosis via nitric oxide production},
journal = {Theranostics},
year = {2023},
volume = {13},
number = {12},
pages = {4182--4196},
doi = {10.7150/thno.83714}
}
EUVIMED